1. Nobiletin resolves left ventricular and renal changes in 2K-1C hypertensive rats.
- Author
-
Iampanichakul, Metee, Poasakate, Anuson, Potue, Prapassorn, Rattanakanokchai, Siwayu, Maneesai, Putcharawipa, Prachaney, Parichat, Settheetham-Ishida, Wannapa, and Pakdeechote, Poungrat
- Subjects
- *
RENIN-angiotensin system , *RATS , *NADPH oxidase , *HYPERTENSION , *LEFT ventricular dysfunction , *ANGIOTENSIN converting enzyme - Abstract
This study investigated the effects of nobiletin on cardiorenal changes and the underlying mechanisms involved in two-kidney, one-clip (2K-1C) hypertension. 2K-1C rats were treated with nobiletin (15 or 30 mg/kg/day) or losartan (10 mg/kg/day) for 4 weeks (n = 8/group). Nobiletin (30 mg/kg) reduced high levels of blood pressure and circulating angiotensin II and angiotensin-converting enzyme activity in 2K-1C rats. Left ventricular (LV) dysfunction and remodelling in 2K-1C rats were alleviated in the nobiletin-treated group (P < 0.05). Nobiletin reduced the upregulation of Ang II type I receptor (AT1R)/JAK (Janus kinase)/STAT (signal transducer and activator of transcription) protein expression in cardiac tissue of 2K-1C rats (P < 0.05). The reduction in kidney function, and accumulation of renal fibrosis in 2K-1C rats were alleviated by nobiletin (P < 0.05). Overexpression of AT1R and NADPH oxidase 4 (Nox4) protein in nonclipped kidney tissue was suppressed in the nobiletin-treated group (P < 0.05). The elevations in oxidative stress parameters and the reductions in antioxidant enzymes were attenuated in 2K-1C rats treated with nobiletin (P < 0.05). In summary, nobiletin had renin-angiotensin system inhibitory and antioxidant effects and attenuated LV dysfunction and remodelling via restoration of the AT1R/JAK/STAT pathway. Nobiletin also resolved renal damage that was related to modulation of the AT1R/Nox4 cascade in 2K-1C hypertension. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF